

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of synapse structural plasticity (GO:0051823) | 6.43210545 |
| 2 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 5.55061084 |
| 3 | striatum development (GO:0021756) | 5.27348318 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.13883397 |
| 5 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.07359316 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.04397352 |
| 7 | negative regulation of interleukin-12 production (GO:0032695) | 5.01895783 |
| 8 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.96931041 |
| 9 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.96483907 |
| 10 | * synaptic transmission, dopaminergic (GO:0001963) | 4.94156860 |
| 11 | dopamine receptor signaling pathway (GO:0007212) | 4.92316528 |
| 12 | synaptic vesicle maturation (GO:0016188) | 4.91774663 |
| 13 | response to peptidoglycan (GO:0032494) | 4.71479553 |
| 14 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.66369909 |
| 15 | auditory behavior (GO:0031223) | 4.66202094 |
| 16 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.65744783 |
| 17 | * prepulse inhibition (GO:0060134) | 4.61974897 |
| 18 | cAMP catabolic process (GO:0006198) | 4.60020608 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.56250595 |
| 20 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.51760862 |
| 21 | * response to amphetamine (GO:0001975) | 4.37860162 |
| 22 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.36302182 |
| 23 | * adenosine receptor signaling pathway (GO:0001973) | 4.31676142 |
| 24 | regulation of chronic inflammatory response (GO:0002676) | 4.29780345 |
| 25 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.28561631 |
| 26 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.24136232 |
| 27 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.23021168 |
| 28 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.21472932 |
| 29 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.21472932 |
| 30 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.13469505 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 4.11519735 |
| 32 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.10906249 |
| 33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.09489702 |
| 34 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.08558548 |
| 35 | response to auditory stimulus (GO:0010996) | 4.08062662 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 4.03904646 |
| 37 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.03454715 |
| 38 | neuromuscular process controlling balance (GO:0050885) | 4.00548544 |
| 39 | regulation of female receptivity (GO:0045924) | 4.00288276 |
| 40 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.95163376 |
| 41 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.95163376 |
| 42 | cyclic nucleotide catabolic process (GO:0009214) | 3.94033802 |
| 43 | cellular response to type I interferon (GO:0071357) | 3.92280234 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.92280234 |
| 45 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.90202432 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 3.89649693 |
| 47 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.89204985 |
| 48 | regulation of vitamin metabolic process (GO:0030656) | 3.88036712 |
| 49 | behavioral response to cocaine (GO:0048148) | 3.87606741 |
| 50 | response to type I interferon (GO:0034340) | 3.87158891 |
| 51 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.87142434 |
| 52 | germinal center formation (GO:0002467) | 3.85999746 |
| 53 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.85300878 |
| 54 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.84904373 |
| 55 | vocalization behavior (GO:0071625) | 3.84293124 |
| 56 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.83203289 |
| 57 | immunoglobulin mediated immune response (GO:0016064) | 3.79227169 |
| 58 | defense response to protozoan (GO:0042832) | 3.77294881 |
| 59 | T-helper 1 type immune response (GO:0042088) | 3.75019742 |
| 60 | regulation of podosome assembly (GO:0071801) | 3.74790224 |
| 61 | positive regulation of heat generation (GO:0031652) | 3.72640061 |
| 62 | response to protozoan (GO:0001562) | 3.71478833 |
| 63 | positive regulation by symbiont of host defense response (GO:0052509) | 3.71386904 |
| 64 | modulation by symbiont of host defense response (GO:0052031) | 3.71386904 |
| 65 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.71386904 |
| 66 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.71386904 |
| 67 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.71386904 |
| 68 | modulation by symbiont of host immune response (GO:0052553) | 3.71386904 |
| 69 | regulation of fever generation (GO:0031620) | 3.68309244 |
| 70 | myeloid dendritic cell differentiation (GO:0043011) | 3.65295284 |
| 71 | regulation of Rap GTPase activity (GO:0032317) | 3.62377570 |
| 72 | positive regulation of Rap GTPase activity (GO:0032854) | 3.62134939 |
| 73 | regulation of interferon-alpha production (GO:0032647) | 3.61759456 |
| 74 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.60917149 |
| 75 | regulation of chemokine biosynthetic process (GO:0045073) | 3.59016944 |
| 76 | visual learning (GO:0008542) | 3.54693224 |
| 77 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.54358006 |
| 78 | negative regulation of amino acid transport (GO:0051956) | 3.51494208 |
| 79 | peristalsis (GO:0030432) | 3.49956842 |
| 80 | T cell migration (GO:0072678) | 3.49679322 |
| 81 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.46049125 |
| 82 | granulocyte activation (GO:0036230) | 3.46031352 |
| 83 | activation of protein kinase A activity (GO:0034199) | 3.45749861 |
| 84 | regulation of neurotransmitter uptake (GO:0051580) | 3.45383280 |
| 85 | positive regulation of type 2 immune response (GO:0002830) | 3.45338791 |
| 86 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45172967 |
| 87 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.43510284 |
| 88 | long-term memory (GO:0007616) | 3.42518644 |
| 89 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.40373545 |
| 90 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.40103821 |
| 91 | positive regulation of membrane potential (GO:0045838) | 3.38826271 |
| 92 | female mating behavior (GO:0060180) | 3.36421281 |
| 93 | leukocyte aggregation (GO:0070486) | 3.34943473 |
| 94 | regulation of interleukin-12 production (GO:0032655) | 3.34305584 |
| 95 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.34203887 |
| 96 | neuronal ion channel clustering (GO:0045161) | 3.33692153 |
| 97 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.33305924 |
| 98 | * positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.33139650 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 3.33036557 |
| 100 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.32342130 |
| 101 | dendritic spine morphogenesis (GO:0060997) | 3.31695687 |
| 102 | synaptic vesicle exocytosis (GO:0016079) | 3.29395326 |
| 103 | mechanosensory behavior (GO:0007638) | 3.28550293 |
| 104 | * cAMP metabolic process (GO:0046058) | 3.26862153 |
| 105 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.26549803 |
| 106 | negative regulation of dendrite development (GO:2000171) | 3.26442729 |
| 107 | neurotransmitter secretion (GO:0007269) | 3.26416770 |
| 108 | visual behavior (GO:0007632) | 3.25638190 |
| 109 | response to muramyl dipeptide (GO:0032495) | 3.24554687 |
| 110 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.24507569 |
| 111 | myeloid dendritic cell activation (GO:0001773) | 3.23396694 |
| 112 | regulation of gamma-delta T cell activation (GO:0046643) | 3.23342796 |
| 113 | exploration behavior (GO:0035640) | 3.21698696 |
| 114 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.21325673 |
| 115 | regulation of mononuclear cell migration (GO:0071675) | 3.20866116 |
| 116 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16505383 |
| 117 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.16160128 |
| 118 | positive regulation of interferon-alpha production (GO:0032727) | 3.15887587 |
| 119 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.14242205 |
| 120 | negative thymic T cell selection (GO:0045060) | 3.12145853 |
| 121 | response to histamine (GO:0034776) | 3.10814029 |
| 122 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.09709704 |
| 123 | regulation of immunoglobulin secretion (GO:0051023) | 3.07906953 |
| 124 | regulation of protein kinase A signaling (GO:0010738) | 3.07591183 |
| 125 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.07528136 |
| 126 | neutrophil activation (GO:0042119) | 3.07452585 |
| 127 | glycine transport (GO:0015816) | 3.07384265 |
| 128 | detection of other organism (GO:0098543) | 3.07355611 |
| 129 | transmission of nerve impulse (GO:0019226) | 3.07265923 |
| 130 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.07190208 |
| 131 | regulation of antigen processing and presentation (GO:0002577) | 3.07145362 |
| 132 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.06736259 |
| 133 | behavioral fear response (GO:0001662) | 3.06031377 |
| 134 | behavioral defense response (GO:0002209) | 3.06031377 |
| 135 | regulation of T-helper cell differentiation (GO:0045622) | 3.05300891 |
| 136 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.04896683 |
| 137 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.04155919 |
| 138 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.03845204 |
| 139 | drinking behavior (GO:0042756) | 3.03545717 |
| 140 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.02321019 |
| 141 | * regulation of synaptic plasticity (GO:0048167) | 3.00984898 |
| 142 | layer formation in cerebral cortex (GO:0021819) | 3.00865151 |
| 143 | monocyte chemotaxis (GO:0002548) | 2.99575452 |
| 144 | cellular response to lipopolysaccharide (GO:0071222) | 2.99086909 |
| 145 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.98938913 |
| 146 | regulation of dendritic spine development (GO:0060998) | 2.97980308 |
| 147 | gamma-aminobutyric acid transport (GO:0015812) | 2.97852411 |
| 148 | regulation of ARF protein signal transduction (GO:0032012) | 2.97402739 |
| 149 | cGMP metabolic process (GO:0046068) | 2.96180632 |
| 150 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.95147586 |
| 151 | negative T cell selection (GO:0043383) | 2.94954851 |
| 152 | protein localization to synapse (GO:0035418) | 2.94948071 |
| 153 | regulation of tolerance induction (GO:0002643) | 2.94716683 |
| 154 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.94709069 |
| 155 | cellular response to molecule of bacterial origin (GO:0071219) | 2.93254573 |
| 156 | detection of bacterium (GO:0016045) | 2.93240165 |
| 157 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.92747950 |
| 158 | myeloid cell activation involved in immune response (GO:0002275) | 2.92388926 |
| 159 | positive regulation of interleukin-12 production (GO:0032735) | 2.92364606 |
| 160 | regulation of synaptic vesicle transport (GO:1902803) | 2.91868343 |
| 161 | B cell mediated immunity (GO:0019724) | 2.91845046 |
| 162 | regulation of type 2 immune response (GO:0002828) | 2.91366664 |
| 163 | dendritic cell differentiation (GO:0097028) | 2.90406654 |
| 164 | * neuron-neuron synaptic transmission (GO:0007270) | 2.89204908 |
| 165 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.88545975 |
| 166 | negative regulation of amine transport (GO:0051953) | 2.88486343 |
| 167 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.88436697 |
| 168 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.88015333 |
| 169 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87737226 |
| 170 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.86514339 |
| 171 | neuronal action potential propagation (GO:0019227) | 2.86449446 |
| 172 | * response to amine (GO:0014075) | 2.86239799 |
| 173 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.85904191 |
| 174 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.85865285 |
| 175 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.83888050 |
| 176 | positive regulation of interleukin-10 production (GO:0032733) | 2.83635861 |
| 177 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.83462510 |
| 178 | cellular response to interferon-gamma (GO:0071346) | 2.82250754 |
| 179 | negative regulation of T cell mediated immunity (GO:0002710) | 2.81972731 |
| 180 | long-term synaptic potentiation (GO:0060291) | 2.81172762 |
| 181 | positive regulation of interleukin-2 production (GO:0032743) | 2.81119604 |
| 182 | positive regulation of tolerance induction (GO:0002645) | 2.80503675 |
| 183 | regulation of heat generation (GO:0031650) | 2.80446392 |
| 184 | positive regulation of acute inflammatory response (GO:0002675) | 2.79806899 |
| 185 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.79146196 |
| 186 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.79084681 |
| 187 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.76375454 |
| 188 | positive regulation of vesicle fusion (GO:0031340) | 2.75458009 |
| 189 | G-protein coupled receptor internalization (GO:0002031) | 2.75093671 |
| 190 | * positive regulation of neurotransmitter transport (GO:0051590) | 2.74784797 |
| 191 | response to morphine (GO:0043278) | 2.74598084 |
| 192 | regulation of vesicle fusion (GO:0031338) | 2.74457466 |
| 193 | learning (GO:0007612) | 2.72426524 |
| 194 | serotonin metabolic process (GO:0042428) | 2.70774926 |
| 195 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.70698623 |
| 196 | * regulation of postsynaptic membrane potential (GO:0060078) | 2.69085103 |
| 197 | neuromuscular process (GO:0050905) | 2.69003348 |
| 198 | associative learning (GO:0008306) | 2.67587918 |
| 199 | negative regulation of cell killing (GO:0031342) | 2.64942376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 4.21192701 |
| 2 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.40954083 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.38599008 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.11362110 |
| 5 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04262600 |
| 6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.97777794 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.75418490 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.67151929 |
| 9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.63528275 |
| 10 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.56456267 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50513476 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.36848647 |
| 13 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.36300093 |
| 14 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.33210601 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.25807403 |
| 16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.25443684 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.22227717 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.16980842 |
| 19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.12362956 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.09595232 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.07376199 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.07376199 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.04446877 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04296020 |
| 25 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.00940201 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.00696988 |
| 27 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.00266445 |
| 28 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97552225 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.93742755 |
| 30 | * MYB_26560356_Chip-Seq_TH2_Human | 1.87473493 |
| 31 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.85657106 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.83150126 |
| 33 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.80781635 |
| 34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.80596249 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80114626 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.80044789 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79093604 |
| 38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78289838 |
| 39 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77619137 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76519523 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.73406844 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.71631891 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.71364320 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.69495482 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68925796 |
| 46 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.68742078 |
| 47 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.67767605 |
| 48 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.67477912 |
| 49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.65739408 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65507282 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.65370186 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61719315 |
| 53 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.61029388 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58063067 |
| 55 | * MYB_26560356_Chip-Seq_TH1_Human | 1.56544735 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55534824 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55372468 |
| 58 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.55366500 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55282722 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.53996692 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51970152 |
| 62 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.49156496 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48608253 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46229433 |
| 65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44900021 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44064348 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44028103 |
| 68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43137092 |
| 69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42518594 |
| 70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.42096200 |
| 71 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41130649 |
| 72 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39041448 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37374496 |
| 74 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35695992 |
| 75 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.34180807 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33990944 |
| 77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33567881 |
| 78 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33362650 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32199015 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31769001 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30784670 |
| 82 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28861570 |
| 83 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.28653807 |
| 84 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27894503 |
| 85 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.27434242 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26540365 |
| 87 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.25758308 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25593242 |
| 89 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24650505 |
| 90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23810833 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21228679 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19920615 |
| 93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19234062 |
| 94 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.18952481 |
| 95 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18645478 |
| 96 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16149550 |
| 97 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15493572 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11901971 |
| 99 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.11460064 |
| 100 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11292560 |
| 101 | MAF_26560356_Chip-Seq_TH1_Human | 1.10611226 |
| 102 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.10284225 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09736415 |
| 104 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08306540 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06230112 |
| 106 | * MYC_22102868_ChIP-Seq_BL_Human | 1.05233595 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03953950 |
| 108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03176616 |
| 109 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01421163 |
| 110 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.00356927 |
| 111 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00001823 |
| 112 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.99655697 |
| 113 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99600406 |
| 114 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99396121 |
| 115 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99053190 |
| 116 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97822370 |
| 117 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.96280789 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96035491 |
| 119 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95756718 |
| 120 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95646178 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95545696 |
| 122 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95057516 |
| 123 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94409079 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93310639 |
| 125 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93157044 |
| 126 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91889979 |
| 127 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.90770089 |
| 128 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90316581 |
| 129 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90315711 |
| 130 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90092504 |
| 131 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88667069 |
| 132 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87570875 |
| 133 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.87004125 |
| 134 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86918926 |
| 135 | AR_19668381_ChIP-Seq_PC3_Human | 0.86801154 |
| 136 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.86076047 |
| 137 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.86011966 |
| 138 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.85921746 |
| 139 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.85802391 |
| 140 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85785571 |
| 141 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85351758 |
| 142 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.83281714 |
| 143 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83135295 |
| 144 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82851175 |
| 145 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82548114 |
| 146 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.82208084 |
| 147 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.81124018 |
| 148 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80681762 |
| 149 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.80354743 |
| 150 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80009005 |
| 151 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.79273527 |
| 152 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.78959901 |
| 153 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.78387562 |
| 154 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.78153137 |
| 155 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.77657564 |
| 156 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.77634687 |
| 157 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.77372702 |
| 158 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.77034884 |
| 159 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.76724065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.62256215 |
| 2 | MP0003724_increased_susceptibility_to | 3.66402450 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.44221849 |
| 4 | * MP0009745_abnormal_behavioral_response | 3.17255801 |
| 5 | * MP0002063_abnormal_learning/memory/cond | 2.87912959 |
| 6 | MP0003880_abnormal_central_pattern | 2.86703225 |
| 7 | MP0001529_abnormal_vocalization | 2.62561295 |
| 8 | MP0002064_seizures | 2.45984565 |
| 9 | MP0002909_abnormal_adrenal_gland | 2.40303186 |
| 10 | MP0009764_decreased_sensitivity_to | 2.33731700 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.33731626 |
| 12 | MP0004270_analgesia | 2.33720539 |
| 13 | MP0009046_muscle_twitch | 2.21919182 |
| 14 | MP0004510_myositis | 2.17132262 |
| 15 | MP0001486_abnormal_startle_reflex | 2.15695680 |
| 16 | * MP0002572_abnormal_emotion/affect_behav | 2.14664833 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.08582821 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.05773770 |
| 19 | MP0001533_abnormal_skeleton_physiology | 2.02423706 |
| 20 | MP0002822_catalepsy | 10.0604412 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 1.98565128 |
| 22 | MP0003303_peritoneal_inflammation | 1.97997431 |
| 23 | MP0002272_abnormal_nervous_system | 1.90248309 |
| 24 | MP0001845_abnormal_inflammatory_respons | 1.88589758 |
| 25 | MP0009840_abnormal_foam_cell | 1.87543140 |
| 26 | MP0002405_respiratory_system_inflammati | 1.86994517 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.85895853 |
| 28 | MP0009278_abnormal_bone_marrow | 1.76654484 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.76227147 |
| 30 | MP0001968_abnormal_touch/_nociception | 1.75728489 |
| 31 | MP0005451_abnormal_body_composition | 1.75534711 |
| 32 | MP0008004_abnormal_stomach_pH | 1.74314454 |
| 33 | MP0004924_abnormal_behavior | 1.72536030 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.72536030 |
| 35 | MP0000343_altered_response_to | 1.69824552 |
| 36 | MP0008469_abnormal_protein_level | 1.64524470 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.63920202 |
| 38 | MP0001853_heart_inflammation | 1.60035274 |
| 39 | MP0005671_abnormal_response_to | 1.56672569 |
| 40 | MP0005409_darkened_coat_color | 1.53487480 |
| 41 | MP0008569_lethality_at_weaning | 1.50986846 |
| 42 | MP0008961_abnormal_basal_metabolism | 1.50469380 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.49065860 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.49000148 |
| 45 | MP0000685_abnormal_immune_system | 1.46213021 |
| 46 | MP0002332_abnormal_exercise_endurance | 1.45146684 |
| 47 | MP0004811_abnormal_neuron_physiology | 1.42093541 |
| 48 | * MP0003075_altered_response_to | 1.40549348 |
| 49 | MP0003448_altered_tumor_morphology | 1.39755401 |
| 50 | MP0008872_abnormal_physiological_respon | 1.38307275 |
| 51 | MP0001835_abnormal_antigen_presentation | 1.35281476 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.34866889 |
| 53 | * MP0008874_decreased_physiological_sensi | 1.34122606 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.33551140 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.33551140 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.32313516 |
| 57 | MP0000858_altered_metastatic_potential | 1.31707682 |
| 58 | MP0002429_abnormal_blood_cell | 1.24118348 |
| 59 | MP0006054_spinal_hemorrhage | 1.23686423 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.22527480 |
| 61 | MP0003633_abnormal_nervous_system | 1.22367336 |
| 62 | MP0002734_abnormal_mechanical_nocicepti | 1.21719444 |
| 63 | MP0006082_CNS_inflammation | 1.20514245 |
| 64 | * MP0001970_abnormal_pain_threshold | 1.18875416 |
| 65 | MP0002722_abnormal_immune_system | 1.18732178 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.18181684 |
| 67 | MP0000013_abnormal_adipose_tissue | 1.17792589 |
| 68 | MP0005310_abnormal_salivary_gland | 1.17449383 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 1.17321831 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 1.16442995 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.16369652 |
| 72 | MP0009785_altered_susceptibility_to | 1.14816455 |
| 73 | MP0005535_abnormal_body_temperature | 1.12843396 |
| 74 | MP0003195_calcinosis | 1.09032569 |
| 75 | MP0001790_abnormal_immune_system | 1.08707140 |
| 76 | MP0005387_immune_system_phenotype | 1.08707140 |
| 77 | MP0003866_abnormal_defecation | 1.06533835 |
| 78 | MP0004858_abnormal_nervous_system | 1.06439870 |
| 79 | MP0003879_abnormal_hair_cell | 1.06280528 |
| 80 | MP0000569_abnormal_digit_pigmentation | 1.06224750 |
| 81 | MP0001348_abnormal_lacrimal_gland | 1.05470911 |
| 82 | MP0010234_abnormal_vibrissa_follicle | 1.04373324 |
| 83 | * MP0002557_abnormal_social/conspecific_i | 1.03462834 |
| 84 | MP0003329_amyloid_beta_deposits | 1.03212227 |
| 85 | MP0009763_increased_sensitivity_to | 1.02080176 |
| 86 | MP0002736_abnormal_nociception_after | 1.01387067 |
| 87 | MP0003690_abnormal_glial_cell | 1.00503982 |
| 88 | MP0001800_abnormal_humoral_immune | 0.99956864 |
| 89 | MP0001188_hyperpigmentation | 0.98481267 |
| 90 | MP0001984_abnormal_olfaction | 0.97679964 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 0.96347769 |
| 92 | MP0000604_amyloidosis | 0.94934376 |
| 93 | MP0001663_abnormal_digestive_system | 0.93840343 |
| 94 | * MP0002723_abnormal_immune_serum | 0.93805095 |
| 95 | * MP0002733_abnormal_thermal_nociception | 0.93144575 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.92480147 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 0.91967798 |
| 98 | MP0001440_abnormal_grooming_behavior | 0.91205475 |
| 99 | * MP0002066_abnormal_motor_capabilities/c | 0.89811071 |
| 100 | MP0001819_abnormal_immune_cell | 0.89346610 |
| 101 | MP0003091_abnormal_cell_migration | 0.88775585 |
| 102 | MP0002420_abnormal_adaptive_immunity | 0.88390633 |
| 103 | MP0002254_reproductive_system_inflammat | 0.85932403 |
| 104 | MP0000920_abnormal_myelination | 0.85662723 |
| 105 | MP0005164_abnormal_response_to | 0.85639784 |
| 106 | MP0002067_abnormal_sensory_capabilities | 0.85258530 |
| 107 | MP0003283_abnormal_digestive_organ | 0.85194936 |
| 108 | MP0002452_abnormal_antigen_presenting | 0.85171387 |
| 109 | MP0001905_abnormal_dopamine_level | 0.85082694 |
| 110 | MP0005025_abnormal_response_to | 0.84186616 |
| 111 | MP0002148_abnormal_hypersensitivity_rea | 0.84186433 |
| 112 | MP0002933_joint_inflammation | 0.83217613 |
| 113 | MP0004885_abnormal_endolymph | 0.82266680 |
| 114 | MP0000703_abnormal_thymus_morphology | 0.82121815 |
| 115 | MP0005390_skeleton_phenotype | 0.81231799 |
| 116 | MP0003763_abnormal_thymus_physiology | 0.80146779 |
| 117 | MP0001873_stomach_inflammation | 0.79701817 |
| 118 | MP0003631_nervous_system_phenotype | 0.79683648 |
| 119 | MP0001177_atelectasis | 0.78816313 |
| 120 | MP0003646_muscle_fatigue | 0.78050618 |
| 121 | MP0002419_abnormal_innate_immunity | 0.77761932 |
| 122 | MP0008260_abnormal_autophagy | 0.77336631 |
| 123 | MP0002006_tumorigenesis | 0.76279565 |
| 124 | MP0003172_abnormal_lysosome_physiology | 0.76068022 |
| 125 | MP0003183_abnormal_peptide_metabolism | 0.75747400 |
| 126 | MP0001502_abnormal_circadian_rhythm | 0.75021044 |
| 127 | * MP0005464_abnormal_platelet_physiology | 0.74204040 |
| 128 | MP0003436_decreased_susceptibility_to | 0.74200206 |
| 129 | MP0004947_skin_inflammation | 0.73888567 |
| 130 | MP0002277_abnormal_respiratory_mucosa | 0.73826331 |
| 131 | MP0001851_eye_inflammation | 0.70311764 |
| 132 | MP0004808_abnormal_hematopoietic_stem | 0.70205778 |
| 133 | MP0002398_abnormal_bone_marrow | 0.69955560 |
| 134 | MP0003828_pulmonary_edema | 0.69019858 |
| 135 | MP0000249_abnormal_blood_vessel | 0.68714250 |
| 136 | MP0000716_abnormal_immune_system | 0.68577750 |
| 137 | MP0000955_abnormal_spinal_cord | 0.68277195 |
| 138 | MP0005165_increased_susceptibility_to | 0.68013332 |
| 139 | MP0002184_abnormal_innervation | 0.67565068 |
| 140 | MP0010155_abnormal_intestine_physiology | 0.66543549 |
| 141 | * MP0005166_decreased_susceptibility_to | 0.65444416 |
| 142 | * MP0002069_abnormal_eating/drinking_beha | 0.65287661 |
| 143 | * MP0004085_abnormal_heartbeat | 0.64866471 |
| 144 | MP0002735_abnormal_chemical_nociception | 0.64320685 |
| 145 | MP0003045_fibrosis | 0.61688278 |
| 146 | MP0004130_abnormal_muscle_cell | 0.61515974 |
| 147 | MP0004883_abnormal_blood_vessel | 0.61235769 |
| 148 | MP0002166_altered_tumor_susceptibility | 0.61234487 |
| 149 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.60976874 |
| 150 | MP0002882_abnormal_neuron_morphology | 0.60352593 |
| 151 | MP0002693_abnormal_pancreas_physiology | 0.58954986 |
| 152 | MP0003795_abnormal_bone_structure | 0.57313961 |
| 153 | MP0000609_abnormal_liver_physiology | 0.55862986 |
| 154 | MP0002877_abnormal_melanocyte_morpholog | 0.54668297 |
| 155 | MP0005647_abnormal_sex_gland | 0.54542949 |
| 156 | MP0005381_digestive/alimentary_phenotyp | 0.53548898 |
| 157 | MP0000490_abnormal_crypts_of | 0.52664771 |
| 158 | MP0001542_abnormal_bone_strength | 0.51054389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 8.58155266 |
| 2 | Focal motor seizures (HP:0011153) | 5.79794952 |
| 3 | Abnormality of macrophages (HP:0004311) | 5.28307732 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.20898525 |
| 5 | Optic neuritis (HP:0100653) | 5.20898525 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.15554833 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.15554833 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 5.15554833 |
| 9 | Orchitis (HP:0100796) | 5.11678179 |
| 10 | Annular pancreas (HP:0001734) | 4.91923924 |
| 11 | Myositis (HP:0100614) | 4.83028247 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.74672929 |
| 13 | Resting tremor (HP:0002322) | 4.68051335 |
| 14 | Recurrent abscess formation (HP:0002722) | 4.50458723 |
| 15 | Focal seizures (HP:0007359) | 4.34288776 |
| 16 | Torticollis (HP:0000473) | 4.29681150 |
| 17 | Polygenic inheritance (HP:0010982) | 3.79994271 |
| 18 | Ankyloglossia (HP:0010296) | 3.66802201 |
| 19 | Poor eye contact (HP:0000817) | 3.65311453 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.64924688 |
| 21 | Craniofacial dystonia (HP:0012179) | 3.58686417 |
| 22 | Focal dystonia (HP:0004373) | 3.58037094 |
| 23 | Vasculitis (HP:0002633) | 3.55979564 |
| 24 | Loss of speech (HP:0002371) | 3.53611563 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.52894231 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.51683202 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 3.50826790 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 3.50353999 |
| 29 | Increased IgM level (HP:0003496) | 3.48218197 |
| 30 | Anxiety (HP:0000739) | 3.47527698 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 3.44408433 |
| 32 | Dysostosis multiplex (HP:0000943) | 3.42094796 |
| 33 | Ankle clonus (HP:0011448) | 3.38756256 |
| 34 | Abnormal social behavior (HP:0012433) | 3.35706363 |
| 35 | Impaired social interactions (HP:0000735) | 3.35706363 |
| 36 | Atrioventricular block (HP:0001678) | 3.35153622 |
| 37 | Keratoconjunctivitis (HP:0001096) | 3.34795257 |
| 38 | Pointed chin (HP:0000307) | 3.28866157 |
| 39 | Depression (HP:0000716) | 3.25813340 |
| 40 | Lower limb amyotrophy (HP:0007210) | 3.24672446 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 3.22205272 |
| 42 | Obstructive lung disease (HP:0006536) | 3.22205272 |
| 43 | Limb hypertonia (HP:0002509) | 3.21475388 |
| 44 | T lymphocytopenia (HP:0005403) | 3.21139633 |
| 45 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.20389025 |
| 46 | Disinhibition (HP:0000734) | 3.18403551 |
| 47 | Visual hallucinations (HP:0002367) | 3.16728435 |
| 48 | Pulmonary infiltrates (HP:0002113) | 3.16242428 |
| 49 | Action tremor (HP:0002345) | 3.15324562 |
| 50 | Recurrent fungal infections (HP:0002841) | 3.14043927 |
| 51 | Gastrointestinal infarctions (HP:0005244) | 3.12837965 |
| 52 | Stereotypic behavior (HP:0000733) | 3.12700745 |
| 53 | Meningitis (HP:0001287) | 3.11866430 |
| 54 | Axonal loss (HP:0003447) | 3.09858825 |
| 55 | Abnormality of oral frenula (HP:0000190) | 3.08059384 |
| 56 | Recurrent viral infections (HP:0004429) | 3.07607931 |
| 57 | Encephalitis (HP:0002383) | 3.03570293 |
| 58 | Gangrene (HP:0100758) | 3.02309207 |
| 59 | Increased IgE level (HP:0003212) | 3.01446360 |
| 60 | Papilledema (HP:0001085) | 3.00033369 |
| 61 | Prolonged QT interval (HP:0001657) | 2.99267785 |
| 62 | Abnormality of T cell number (HP:0011839) | 2.98381156 |
| 63 | Dysmetric saccades (HP:0000641) | 2.94318744 |
| 64 | Hemiplegia (HP:0002301) | 2.88921183 |
| 65 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.88732030 |
| 66 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.87938655 |
| 67 | Increased serum ferritin (HP:0003281) | 2.87293479 |
| 68 | Distal lower limb amyotrophy (HP:0008944) | 2.86860593 |
| 69 | Urinary urgency (HP:0000012) | 2.85332190 |
| 70 | Hemoptysis (HP:0002105) | 2.84628301 |
| 71 | Purpura (HP:0000979) | 2.84368089 |
| 72 | Petechiae (HP:0000967) | 2.84021613 |
| 73 | Autoimmune hemolytic anemia (HP:0001890) | 2.83023837 |
| 74 | Recurrent skin infections (HP:0001581) | 2.82704513 |
| 75 | Abnormality of the periventricular white matter (HP:0002518) | 2.77807102 |
| 76 | Broad-based gait (HP:0002136) | 2.76119492 |
| 77 | Upper limb amyotrophy (HP:0009129) | 2.70343260 |
| 78 | Distal upper limb amyotrophy (HP:0007149) | 2.70343260 |
| 79 | Gastrointestinal stroma tumor (HP:0100723) | 2.68729491 |
| 80 | Heart block (HP:0012722) | 2.68167554 |
| 81 | Hematochezia (HP:0002573) | 2.62255467 |
| 82 | Episodic fever (HP:0001954) | 2.61092569 |
| 83 | Dysdiadochokinesis (HP:0002075) | 2.59365850 |
| 84 | Arterial thrombosis (HP:0004420) | 2.57876397 |
| 85 | Chronic otitis media (HP:0000389) | 2.52709507 |
| 86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.52650473 |
| 87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.52650473 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.52650473 |
| 89 | Nuclear cataract (HP:0100018) | 2.50785674 |
| 90 | Abnormal EKG (HP:0003115) | 2.50325467 |
| 91 | Urticaria (HP:0001025) | 2.49593288 |
| 92 | Spontaneous hematomas (HP:0007420) | 2.48997839 |
| 93 | Anorexia (HP:0002039) | 2.48945226 |
| 94 | Hypergammaglobulinemia (HP:0010702) | 2.48599397 |
| 95 | Truncal ataxia (HP:0002078) | 2.47923495 |
| 96 | Leukocytosis (HP:0001974) | 2.44359929 |
| 97 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.44275851 |
| 98 | Spinal canal stenosis (HP:0003416) | 2.43488617 |
| 99 | Amyloidosis (HP:0011034) | 2.43294138 |
| 100 | Generalized tonic-clonic seizures (HP:0002069) | 2.43167536 |
| 101 | Supranuclear gaze palsy (HP:0000605) | 2.42935190 |
| 102 | Gaze-evoked nystagmus (HP:0000640) | 2.42890216 |
| 103 | Dysmetria (HP:0001310) | 2.41587446 |
| 104 | Polyneuropathy (HP:0001271) | 2.40514091 |
| 105 | Progressive inability to walk (HP:0002505) | 2.39648062 |
| 106 | Interstitial pulmonary disease (HP:0006530) | 2.39621289 |
| 107 | Abnormal atrioventricular conduction (HP:0005150) | 2.39490590 |
| 108 | Joint swelling (HP:0001386) | 2.36927157 |
| 109 | Pulmonary embolism (HP:0002204) | 2.35279748 |
| 110 | Abnormality of the pleura (HP:0002103) | 2.34991425 |
| 111 | Gingivitis (HP:0000230) | 2.34840340 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 2.34042080 |
| 113 | Postural instability (HP:0002172) | 2.33794542 |
| 114 | Lymphopenia (HP:0001888) | 2.33040972 |
| 115 | Mucopolysacchariduria (HP:0008155) | 2.31751434 |
| 116 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.31751434 |
| 117 | Progressive neurologic deterioration (HP:0002344) | 2.30591987 |
| 118 | Acute lymphatic leukemia (HP:0006721) | 2.30572104 |
| 119 | Absence seizures (HP:0002121) | 2.28892432 |
| 120 | Prolonged bleeding time (HP:0003010) | 2.28423651 |
| 121 | Spastic gait (HP:0002064) | 2.24555066 |
| 122 | Scanning speech (HP:0002168) | 2.24408967 |
| 123 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.22598108 |
| 124 | Febrile seizures (HP:0002373) | 2.20770285 |
| 125 | Abnormality of T cells (HP:0002843) | 2.20662182 |
| 126 | Epileptic encephalopathy (HP:0200134) | 2.19524374 |
| 127 | Hepatosplenomegaly (HP:0001433) | 2.18688253 |
| 128 | Impaired smooth pursuit (HP:0007772) | 2.18432004 |
| 129 | Glomerulonephritis (HP:0000099) | 2.18378526 |
| 130 | Colitis (HP:0002583) | 2.18198990 |
| 131 | Neurofibrillary tangles (HP:0002185) | 2.16726938 |
| 132 | Epistaxis (HP:0000421) | 2.16367728 |
| 133 | Abnormal eating behavior (HP:0100738) | 2.16048089 |
| 134 | Fatigue (HP:0012378) | 2.15937860 |
| 135 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.15882158 |
| 136 | Clonus (HP:0002169) | 2.14362223 |
| 137 | Chest pain (HP:0100749) | 2.14137485 |
| 138 | Abnormality of B cell number (HP:0010975) | 2.13360184 |
| 139 | IgA deficiency (HP:0002720) | 2.13272352 |
| 140 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.12174240 |
| 141 | Tetraplegia (HP:0002445) | 2.11369650 |
| 142 | Cellulitis (HP:0100658) | 2.11019342 |
| 143 | Stomatitis (HP:0010280) | 2.10244792 |
| 144 | Dialeptic seizures (HP:0011146) | 2.10132272 |
| 145 | Parakeratosis (HP:0001036) | 2.09680831 |
| 146 | Arthralgia (HP:0002829) | 2.09131931 |
| 147 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.08449568 |
| 148 | Recurrent cutaneous fungal infections (HP:0011370) | 2.08449568 |
| 149 | Megalencephaly (HP:0001355) | 2.07721405 |
| 150 | Restrictive lung disease (HP:0002091) | 2.06188406 |
| 151 | Diminished motivation (HP:0000745) | 2.05760445 |
| 152 | B lymphocytopenia (HP:0010976) | 2.05388478 |
| 153 | Bradykinesia (HP:0002067) | 2.05086357 |
| 154 | Truncus arteriosus (HP:0001660) | 2.05048347 |
| 155 | Vertigo (HP:0002321) | 2.04941995 |
| 156 | Intention tremor (HP:0002080) | 2.04930657 |
| 157 | Nausea (HP:0002018) | 2.04296231 |
| 158 | Palpebral edema (HP:0100540) | 2.03709950 |
| 159 | Inflammation of the large intestine (HP:0002037) | 2.03187924 |
| 160 | Acne (HP:0001061) | 2.02990371 |
| 161 | Recurrent bronchitis (HP:0002837) | 2.02217313 |
| 162 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.02135383 |
| 163 | Limb dystonia (HP:0002451) | 2.01266987 |
| 164 | Deep palmar crease (HP:0006191) | 2.01139963 |
| 165 | Mediastinal lymphadenopathy (HP:0100721) | 1.99511095 |
| 166 | Impaired vibratory sensation (HP:0002495) | 1.99458706 |
| 167 | Combined immunodeficiency (HP:0005387) | 1.98713432 |
| 168 | Primary atrial arrhythmia (HP:0001692) | 1.97503888 |
| 169 | Abnormality of saccadic eye movements (HP:0000570) | 1.95885557 |
| 170 | Ventricular fibrillation (HP:0001663) | 1.94371939 |
| 171 | Atrial fibrillation (HP:0005110) | 1.91691227 |
| 172 | Bundle branch block (HP:0011710) | 1.89901317 |
| 173 | Mutism (HP:0002300) | 1.88433853 |
| 174 | Eczematoid dermatitis (HP:0000976) | 1.87145507 |
| 175 | Abnormality of the nasal mucosa (HP:0000433) | 1.86361838 |
| 176 | Supraventricular tachycardia (HP:0004755) | 1.85569963 |
| 177 | Neuronal loss in central nervous system (HP:0002529) | 1.85316279 |
| 178 | Obsessive-compulsive behavior (HP:0000722) | 1.82748627 |
| 179 | Nasal polyposis (HP:0100582) | 1.82746650 |
| 180 | Striae distensae (HP:0001065) | 1.82220052 |
| 181 | Lower limb muscle weakness (HP:0007340) | 1.81850627 |
| 182 | Onion bulb formation (HP:0003383) | 1.81326023 |
| 183 | Atonic seizures (HP:0010819) | 1.80712419 |
| 184 | Lower limb asymmetry (HP:0100559) | 1.80640080 |
| 185 | Polycythemia (HP:0001901) | 1.80258940 |
| 186 | Supraventricular arrhythmia (HP:0005115) | 1.79340808 |
| 187 | Ocular albinism (HP:0001107) | 1.77368840 |
| 188 | Hemiparesis (HP:0001269) | 1.77284063 |
| 189 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.77094999 |
| 190 | Obstructive sleep apnea (HP:0002870) | 1.73335177 |
| 191 | Apathy (HP:0000741) | 1.73232923 |
| 192 | Porencephaly (HP:0002132) | 1.72971140 |
| 193 | Dysphonia (HP:0001618) | 1.71527937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 7.70140752 |
| 2 | IRAK3 | 4.95129384 |
| 3 | RIPK4 | 3.24406713 |
| 4 | MAP3K13 | 3.14488096 |
| 5 | MAP3K9 | 3.09955819 |
| 6 | KSR2 | 3.00250715 |
| 7 | NTRK3 | 2.93808986 |
| 8 | IRAK4 | 2.82642950 |
| 9 | MATK | 2.67885920 |
| 10 | TAOK2 | 2.61600436 |
| 11 | NME2 | 2.59846294 |
| 12 | FES | 2.55621185 |
| 13 | GRK7 | 2.47277993 |
| 14 | DAPK2 | 2.47069030 |
| 15 | BLK | 2.34824243 |
| 16 | PRKD3 | 2.24346301 |
| 17 | CSK | 2.24316219 |
| 18 | CAMKK1 | 2.19642198 |
| 19 | MAP3K11 | 2.17520563 |
| 20 | TAOK1 | 2.17511760 |
| 21 | DDR2 | 2.10107541 |
| 22 | FGR | 1.99041324 |
| 23 | TRIB3 | 1.94499423 |
| 24 | ERN1 | 1.88282773 |
| 25 | MAP2K3 | 1.84435220 |
| 26 | ARAF | 1.82913932 |
| 27 | MAP3K3 | 1.75667597 |
| 28 | SIK2 | 1.72211240 |
| 29 | NTRK1 | 1.48329420 |
| 30 | RAF1 | 1.43685689 |
| 31 | MAP3K2 | 1.42929930 |
| 32 | TYRO3 | 1.42543486 |
| 33 | NTRK2 | 1.40638337 |
| 34 | PRKCH | 1.38589684 |
| 35 | KSR1 | 1.38122805 |
| 36 | CDK5 | 1.37477815 |
| 37 | IKBKE | 1.36908337 |
| 38 | MINK1 | 1.34706314 |
| 39 | MAP4K1 | 1.33763696 |
| 40 | CHUK | 1.31369216 |
| 41 | IRAK1 | 1.29526100 |
| 42 | CDC42BPA | 1.27928488 |
| 43 | SIK3 | 1.25554134 |
| 44 | LYN | 1.24981031 |
| 45 | DAPK1 | 1.24730301 |
| 46 | CAMKK2 | 1.24710502 |
| 47 | JAK1 | 1.23303806 |
| 48 | BTK | 1.22798968 |
| 49 | RIPK1 | 1.22214573 |
| 50 | PIM2 | 1.21466037 |
| 51 | IRAK2 | 1.21210561 |
| 52 | BMPR2 | 1.19976894 |
| 53 | MAP3K14 | 1.18983715 |
| 54 | PAK6 | 1.16720463 |
| 55 | MAP3K1 | 1.11533248 |
| 56 | SGK3 | 1.06384314 |
| 57 | RET | 1.05348104 |
| 58 | ALK | 1.04696431 |
| 59 | JAK3 | 1.02919208 |
| 60 | HCK | 1.02383621 |
| 61 | ADRBK2 | 1.00542024 |
| 62 | LCK | 0.98810825 |
| 63 | TBK1 | 0.98079458 |
| 64 | TAOK3 | 0.96324857 |
| 65 | MARK2 | 0.95439069 |
| 66 | CSF1R | 0.95297277 |
| 67 | TNIK | 0.93643128 |
| 68 | TXK | 0.92700467 |
| 69 | SGK2 | 0.90518501 |
| 70 | TGFBR2 | 0.88848690 |
| 71 | TESK2 | 0.88791428 |
| 72 | PDK1 | 0.87719411 |
| 73 | PRKD2 | 0.86265297 |
| 74 | SGK494 | 0.83267755 |
| 75 | SGK223 | 0.83267755 |
| 76 | SGK1 | 0.82896498 |
| 77 | PDPK1 | 0.82341597 |
| 78 | MAP3K5 | 0.81042560 |
| 79 | MAP3K4 | 0.80231869 |
| 80 | STK11 | 0.78354343 |
| 81 | STK10 | 0.77444277 |
| 82 | IKBKB | 0.75478109 |
| 83 | EPHA3 | 0.74020349 |
| 84 | TYK2 | 0.72816986 |
| 85 | DMPK | 0.71393228 |
| 86 | PRPF4B | 0.69699701 |
| 87 | TNK2 | 0.68959602 |
| 88 | PIM1 | 0.68635278 |
| 89 | SYK | 0.68357123 |
| 90 | ACVR1B | 0.66208138 |
| 91 | PTK2B | 0.64180370 |
| 92 | PINK1 | 0.62776367 |
| 93 | JAK2 | 0.62062155 |
| 94 | FYN | 0.57846061 |
| 95 | SIK1 | 0.57425254 |
| 96 | EPHB1 | 0.55017006 |
| 97 | KIT | 0.54900190 |
| 98 | PRKCQ | 0.54680162 |
| 99 | MAP3K7 | 0.53438900 |
| 100 | CAMK1 | 0.52635417 |
| 101 | MARK3 | 0.51781737 |
| 102 | FGFR3 | 0.51341946 |
| 103 | STK38 | 0.50868032 |
| 104 | BMX | 0.50588086 |
| 105 | MARK1 | 0.50052922 |
| 106 | ABL2 | 0.49355002 |
| 107 | CAMK4 | 0.48750633 |
| 108 | DAPK3 | 0.48174938 |
| 109 | TEC | 0.47143617 |
| 110 | MOS | 0.46879773 |
| 111 | MAP2K6 | 0.46685590 |
| 112 | CLK1 | 0.46334930 |
| 113 | MAP2K1 | 0.45173635 |
| 114 | CDK15 | 0.44239976 |
| 115 | ZAP70 | 0.44207498 |
| 116 | RPS6KA3 | 0.43739917 |
| 117 | SCYL2 | 0.42936152 |
| 118 | CDK18 | 0.42502273 |
| 119 | UHMK1 | 0.41211627 |
| 120 | PRKCZ | 0.40529584 |
| 121 | PKN2 | 0.40415127 |
| 122 | CDK14 | 0.40396212 |
| 123 | MAP2K7 | 0.39508028 |
| 124 | MAPK4 | 0.39377018 |
| 125 | CDK11A | 0.37491431 |
| 126 | LRRK2 | 0.37204395 |
| 127 | MAP2K4 | 0.35665410 |
| 128 | MAPK7 | 0.35409155 |
| 129 | MAPK10 | 0.34335507 |
| 130 | DYRK3 | 0.33890842 |
| 131 | LMTK2 | 0.33686960 |
| 132 | CDK4 | 0.32718842 |
| 133 | FGFR4 | 0.32282209 |
| 134 | PKN1 | 0.31724956 |
| 135 | GRK6 | 0.30990386 |
| 136 | ITK | 0.30377450 |
| 137 | CAMK2A | 0.30356290 |
| 138 | RPS6KL1 | 0.30057247 |
| 139 | RPS6KC1 | 0.30057247 |
| 140 | HIPK2 | 0.29535944 |
| 141 | PRKACG | 0.29507000 |
| 142 | KDR | 0.29355420 |
| 143 | NEK1 | 0.29069327 |
| 144 | SMG1 | 0.28428373 |
| 145 | PDGFRA | 0.28057526 |
| 146 | PRKCG | 0.28033931 |
| 147 | PRKCB | 0.27426995 |
| 148 | INSR | 0.27416377 |
| 149 | PDGFRB | 0.26088342 |
| 150 | NLK | 0.25930467 |
| 151 | MAPK12 | 0.25252459 |
| 152 | ABL1 | 0.25187728 |
| 153 | CDK6 | 0.22590492 |
| 154 | RPS6KA6 | 0.22363235 |
| 155 | DYRK1B | 0.21477890 |
| 156 | MAPKAPK2 | 0.20029001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.44170444 |
| 2 | Cocaine addiction_Homo sapiens_hsa05030 | 2.59772233 |
| 3 | Morphine addiction_Homo sapiens_hsa05032 | 2.58160783 |
| 4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.43479312 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.36865505 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.35438336 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.35124999 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.28573264 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.21867718 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.20019425 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.19783735 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 2.15345674 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 2.12761903 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 2.05873136 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.03490266 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.98016854 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.93588581 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.93228980 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.92934245 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.88357160 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.82026047 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.80478659 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.79347608 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.75943753 |
| 25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.69175156 |
| 26 | Nicotine addiction_Homo sapiens_hsa05033 | 1.68805230 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67123358 |
| 28 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.60256057 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.57287683 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.55864098 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.51869365 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51474039 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48874285 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.48493934 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.48299600 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.42570678 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42164189 |
| 38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.40291161 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.39090551 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37392388 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34924495 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32813020 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.30270521 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28164809 |
| 45 | Gap junction_Homo sapiens_hsa04540 | 1.27735255 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.25152958 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21019207 |
| 48 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.20505847 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.19146088 |
| 50 | Insulin secretion_Homo sapiens_hsa04911 | 1.18866707 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.14653249 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14590144 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 1.14566245 |
| 54 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13522985 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.13017733 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12528324 |
| 57 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09443342 |
| 58 | Glioma_Homo sapiens_hsa05214 | 1.08251269 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07707415 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07215219 |
| 61 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06491954 |
| 62 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05820924 |
| 63 | Long-term depression_Homo sapiens_hsa04730 | 1.04446835 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02345291 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 1.01888576 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.01131564 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00546246 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99644100 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.99532402 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98327162 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.98270773 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97020828 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96129135 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94343430 |
| 75 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92041203 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88946290 |
| 77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88759059 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88471553 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88185975 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88128331 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.87541184 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85231159 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82898264 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82817769 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.82540273 |
| 86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79964190 |
| 87 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.79886388 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78864809 |
| 89 | Taste transduction_Homo sapiens_hsa04742 | 0.78010485 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76618302 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75457250 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.75386058 |
| 93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75250339 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74719145 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72474284 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71180720 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69934129 |
| 98 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69724812 |
| 99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.69563255 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69086964 |
| 101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68136026 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67161656 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66367579 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64878914 |
| 105 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64110135 |
| 106 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63824954 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.60711661 |
| 108 | Tuberculosis_Homo sapiens_hsa05152 | 0.60194000 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59788937 |
| 110 | * Alcoholism_Homo sapiens_hsa05034 | 0.58779542 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58111520 |
| 112 | Melanogenesis_Homo sapiens_hsa04916 | 0.57825357 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57362862 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54441630 |
| 115 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54163809 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53585031 |
| 117 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52605226 |
| 118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52525224 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52453799 |
| 120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.51890991 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51324203 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.51252345 |
| 123 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50545853 |
| 124 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50269960 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50024629 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49612837 |
| 127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48973946 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48670288 |
| 129 | Measles_Homo sapiens_hsa05162 | 0.48607618 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.48511807 |
| 131 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.48454808 |
| 132 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48452170 |
| 133 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.48073000 |
| 134 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48033281 |
| 135 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47956132 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47893132 |
| 137 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47865973 |
| 138 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47838877 |
| 139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47491881 |
| 140 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47005898 |
| 141 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44164218 |
| 142 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40128754 |
| 143 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37504355 |
| 144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35377994 |
| 145 | Insulin resistance_Homo sapiens_hsa04931 | 0.29678655 |
| 146 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29249838 |
| 147 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.13974489 |
| 148 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.13514693 |
| 149 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.13275714 |
| 150 | Prostate cancer_Homo sapiens_hsa05215 | 0.12209013 |
| 151 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11257266 |
| 152 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.10449333 |
| 153 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.08642036 |

